Acucela: Acucela Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $250

SummaryAcucela Inc Acucela a subsidiary of Kubota Pharmaceutical Holding is a developer of treatments for degenerative eye diseases and pharmaceutical compound screening system. The company develops its products using its visual cycle modulation technology...